about
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsColorectal Carcinoma: A General Overview and Future Perspectives in Colorectal CancerA SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG.cis-Pt I2(NH3)2: a reappraisal.Which Metals are Green for Catalysis? Comparison of the Toxicities of Ni, Cu, Fe, Pd, Pt, Rh, and Au Salts.Synchrotron X-Ray Fluorescence Nanoprobe Reveals Target Sites for Organo-Osmium Complex in Human Ovarian Cancer Cells.Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.The melanocortin signaling cAMP axis accelerates repair and reduces mutagenesis of platinum-induced DNA damage.Differences in cisplatin distribution in sensitive and resistant ovarian cancer cells: a TEM/NanoSIMS study.Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels.Development of trackable metal-based drugs: new generation of therapeutic agents.Anticancer potential of a photoactivated transplatin derivative containing the methylazaindole ligand mediated by ROS generation and DNA cleavage.Response from Boal and Rosenzweig to Crystallography and chemistry should always go together: a cautionary tale of protein complexes with cisplatin and carboplatin.Palladacyclic Conjugate Group Promotes Hybridization of Short Oligonucleotides.
P2860
Q28066801-65B14CC0-1D23-4C5D-8237-49338F8A8EE8Q30238915-E26A96D9-4504-4249-8609-12E3282990ECQ37500149-E1DB9709-2737-4F00-A3F7-49CEECF1AF6DQ38847816-ECE0E2FD-9BBA-4364-9C1F-5056AA971C3AQ38929495-F6AFD24F-0BEA-4CB1-9A66-C5597C1E50CBQ39067087-B552B3D7-C58A-4382-AFB6-E87B02EDE150Q39824889-BB01DD95-52B7-447C-9F29-0EED560EAFFBQ41718210-A80B678E-7F28-414F-8F56-5848CB754056Q47672975-03157E33-96F3-4312-B712-21AF97FFC8DEQ48131391-1B9D0736-3671-480A-AAC5-9842C9A75A0DQ50856412-D8647437-5C18-4B7A-B2F7-58B2312CE48EQ52860409-4E727FC7-D8F3-4064-9FEC-CC26214E338FQ53198697-9AF6077C-66FB-4378-A4B2-E12F1EDB0E84Q55617089-F7A453FD-32A4-4741-A34D-5C9D6261D407
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Third row transition metals for the treatment of cancer
@ast
Third row transition metals for the treatment of cancer
@en
type
label
Third row transition metals for the treatment of cancer
@ast
Third row transition metals for the treatment of cancer
@en
prefLabel
Third row transition metals for the treatment of cancer
@ast
Third row transition metals for the treatment of cancer
@en
P2860
P356
P1476
Third row transition metals for the treatment of cancer
@en
P2093
Kogularamanan Suntharalingam
Timothy C Johnstone
P2860
P356
10.1098/RSTA.2014.0185
P407
P577
2015-03-01T00:00:00Z